Abstract
Purpose
To compare surgical success rates and complications of silicone tube intubation using 0.64-mm- and 0.94-mm-diam-eter tubes in adult patients with nasolacrimal duct stenosis.
Methods
In 62 eyes of 36 patients diagnosed with nasolacrimal duct stenosis who had undergone silicone tube intubation, we surveyed sex, age, symptom duration, time of tube removal, mean follow-up period, and surgical success rate between two groups divided by silicone tube diameter, 0.64 mm and 0.94 mm. By preoperative syringing test and dacryocystography, we examined the surgical results and complications of the two groups.
Results
The silicone tube diameter was 0.64 mm in 43 eyes (69.4%) and 0.94 mm in 19 eyes (30.2%). The surgical success rates in the two groups were 84.1% (36 eyes) and 78.9% (15 eyes), respectively, but the difference was not significant statistically. The surgical success rate was higher in partial stenosis than in complete stenosis but was not different according to silicone tube diameter according to preoperative syringing test and dacryocystography. Silicone tube disconnection and bending were only observed in 0.94-mm-diameter silicone tubes.
References
1. Oum JS, Park JW, Choi YK, et al. Result of partial nasolacrimal duct obstruction after silicone tube intubation. J Korean Ophthalmol Soc. 2004; 45:1777–82.
3. Beigi B, O'Keefe M. Results of Crawford tube intubation in children. Acta Ophthalmol (Copenh). 1993; 71:405–7.
4. Ewing AE. Roentgen ray demonstration of the lacrimal abscess cavity. Am J Ophthalmol. 1909; 24:1–4.
5. Milder B, Demorest BH. Dacryocystography. I. The normal abdominal apparatus. AMA Arch Ophthalmol. 1954; 51:180–95.
6. Jung JJ, Jang SY, Jang JW, In JH. Comparison results of silicone tube intubation according to syringing and dacryocystography. J Korean Ophthalmol Soc. 2014; 55:1584–8.
7. Park JJ, Shin DS, Hong SP, Lee KW. Effects of double silicone tube intubation for nasolacrimal duct obstruction in adults. J Korean Ophthalmol Soc. 2005; 46:1951–6.
8. Moscato EE, Dolmetsch AM, Silkiss RZ, Seiff SR. Silicone abdominal for the treatment of epiphora in adults with presumed functional nasolacrimal duct obstruction. Ophthal Plast Reconstr Surg. 2012; 28:35–9.
9. Kwon YH, Lee YJ. abdominal results of silicone tube intubation in incomplete nasolacrimal duct obstruction (NLDO). J Korean Ophthalmol Soc. 2008; 49:190–4.
10. Kim YR, Ahn M. Long term effect of double silicone tube abdominal for acquired nasolacrimal duct obstruction. J Korean Ophthalmol Soc. 2012; 53:1554–8.
11. Kashkouli MB, Kempster RC, Galloway GD, Beigi B. Monocanalicular versus bicanalicular silicone intubation for nasolacrimal duct stenosis in adults. Ophthal Plast Reconstr Surg. 2005; 21:142–7.
12. Andalib D, Nabie R, Abbasi L. Silicone intubation for nasolacrimal duct stenosis in adults: monocanalicular or bicanalicular intubation. J Craniofac Surg. 2014; 25:1009–11.
13. Tucker SM, Linberg JV, Nguyen LL, et al. Measurement of the abdominal to fluid flow within the lacrimal outflow system. Ophthalmology. 1995; 102:1639–45.
14. Demirci H, Elner VM. Double silicone tube intubation for the abdominal of partial lacrimal system obstruction. Ophthalmology. 2008; 115:383–5.
15. Paik JS, Cho WK, Yang SW. Bicanalicular double silicone stenting in endoscopic dacryocystorhinostomy with lacrimal trephination in distal or common canalicular obstruction. Eur Arch Otorhinolaryngol. 2012; 269:1605–11.
16. Hwang SW, Khwarg SI, Kim JH, et al. Bicanalicular double abdominal intubation in external dacryocystorhinostomy and canal-iculoplasty for distal canalicular obstruction. Acta Ophthalmol. 2009; 87:438–42.
Table 1.
0.64 mm | 0.94 mm | p-value | |
---|---|---|---|
Patients (number) | 0.142* | ||
Male | 13/26 (50.0%) | 2/10 (20.0%) | |
Female | 13/26 (50.0%) | 8/10 (80.0%) | |
Age (years) | 62.3 ± 10.9 | 58.6 ± 10.3 | 0.259† |
Laterality (eyes) | 0.402* | ||
Right | 23/43 (53.5%) | 8/19 (42.1%) | |
Left | 20/43 (46.5%) | 11/19 (57.9%) | |
Duration of symptom (months) | 12.7 ± 6.4 | 18.2± 4.2 | 0.535† |
Time of tube removal (months) | 6.1 ± 1.5 | 6.2 ± 1.2 | 0.651† |
Follow up time (months) | 8.4 ± 2.5 | 8.1 ± 2.2 | 0.580† |
Success rate | 36/43 (84.1%) | 15/19 (78.9%) | 0.287* |
Table 2.
Syringing test | 0.64 mm (success rate) | 0.94 mm (success rate) | p-value* |
---|---|---|---|
Well passed | 20/22 (90.1%) | 9/11 (81.8%) | 0.206* |
Passed with regurgitation | 16/21 (76.2%) | 6/8 (75.0%) | 0.744* |
p-value | 0.045* | 0.046* |